Therapeutic Asset Ratings
13,155 results matching 1 filter
91,564
assets
·
7,904
sponsors
·
3,128
indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
Tipiracil
Rectal Carcinoma
Sun Yat-sen University
P2
B
(60)
Tislelizumab
Cancer Of Unknown Primary Site
SOLTI Breast Cancer Research Group
P2
B
(60)
Tislelizumab
Prostate Cancer
Shanghai Changzheng Hospital
P2
B
(60)
Tislelizumab
Colorectal Carcinoma
Fudan University
P2
B
(60)
Tocilizumab
Melanoma
University of Southern California
P2
B
(60)
Toripalimab
Clear Cell Renal Carcinoma
RenJi Hospital
P2
B
(60)
Toripalimab
Kidney Cancer
West China Hospital
P2
B
(60)
Toripalimab
Neoplasm
Suzhou Abogen Biosciences Co., Ltd.
P2
B
(60)
Trametinib
Lung Cancer
Sun Yat-sen University
P2
B
(60)
Trametinib
Refractory Malignant Neoplasm
Shanghai Chest Hospital
P2
B
(60)
Trastuzumab
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Trastuzumab
Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Trastuzumab
Cervical Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Trastuzumab
Triple-Positive Breast Carcinoma
Second Affiliated Hospital, School of Medicine, Zhejiang University
P2
B
(60)
Trastuzumab
Rectal Carcinoma
Peking Union Medical College Hospital
P2
B
(60)
Trastuzumab Deruxtecan
Colon Adenocarcinoma
Gruppo Oncologico del Nord-Ovest
P2
B
(60)
Trastuzumab Deruxtecan
Neoplasm
Lei Zheng
P2
B
(60)
Trastuzumab Deruxtecan
Hormone Receptor-Positive Breast Cancer
National Cancer Institute (NCI)
P2
B
(60)
Trastuzumab Deruxtecan
Invasive Breast Carcinoma
National Cancer Institute (NCI)
P2
B
(60)
Trastuzumab Emtansine
Lymphoma
Memorial Sloan Kettering Cancer Center
P2
B
(60)
Trastuzumab Emtansine
Ovarian Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Trastuzumab Emtansine
Exocrine Pancreatic Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Trastuzumab Emtansine
Prostate Carcinoma
OHSU Knight Cancer Institute
P2
B
(60)
Treg Cells
Chronic Myeloid Leukemia
Masonic Cancer Center, University of Minnesota
P2
B
(60)
Treosulfan
Disease Related To Hematopoietic Stem Cell Transplant
Federal Research Institute of Pediatric Hematology, Oncology and Immunology
P2
B
(60)
Showing 2201 to 2225 of 13,155 assets
Previous
Page 89 of 527
Next